What opportunities can French heart failure advocates leverage to improve care across the country?

News & Events

22 February 2023
AUTHOR: Ellen McIntosh


In France, there is a shared national vision for heart failure, and there has been much progress in terms of policy, creating exciting opportunities for advocates. For instance, the law allows for experimentation with innovative ways of improving the heart failure care model. What practical steps can heart failure advocates in France take to address the barriers to care and leverage existing opportunities in the country?

Our latest policy briefing takes an in-depth look at this question, examining existing opportunities to advocate for guideline-recommended care in France and recommending specific actions. These include calling on regional health authorities to prioritise heart failure in their health investment plans and using freely available online heart failure data to make a strong case for addressing gaps in care.

This briefing is the second in our new series, From guidelines to action: opportunities for heart failure advocacy, which aims to equip national advocates with a targeted analysis of the opportunities available in their countries, including specific actions they can take. The recommended actions are supported by successful examples from a number of health advocacy areas and interviews with national heart failure experts. The French briefing follows the Spanish report published last year, with upcoming reports focusing on Italy and Germany.

Download the report


More from News & Events

9 things we learnt from the Heart Failure Policy Summit 2022
9 things we learnt from the Heart Failure Policy Summit 2022...
13 January 2023
Last year's Summit brought together experts from the heart failure and wider health advocacy communities. Here, we reflect on some learning points....
Read article
Innovation in heart failure: how can we ensure early diagnos
Innovation in heart failure: how can we ensure early diagnos...
08 December 2022
Our ‘Innovation in heart failure: early diagnosis in community settings’ report outlines the urgent need to boost timely diagnosis and presents a variety of promising initiativ...
Read article
The Heart Failure Policy Network is an independent, multidisciplinary platform made possible with financial support from AstraZeneca, CSL Vifor, Boehringer Ingelheim and Roche Diagnostics. The content produced by the Network is not biased toward any specific treatment or therapy. All outputs are guided and endorsed by the Network’s members. All members provide their time for free. The Network is hosted by The Health Policy Partnership .